Mixed Mesodermal (Mullerian) Tumor

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Mixed Mesodermal (Mullerian) Tumor trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT05256225

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci…

This phase III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin Hylecta \[TM\]) or pertuzumab, trastuzumab and hyaluronidase-zzxf (Phesg…

United States360 participantsStarted 2022-11-16

Treatment: Biospecimen Collection, Carboplatin

All recent trials (7 shown)

Active — Not RecruitingNot Applicable

NCT01737619

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

This clinical trial studies positron emission tomography (PET)/computed tomography (CT) and lymph node mapping in finding lymph node metastasis in patients with…

United States101 participantsStarted 2013-04-03

Treatment: Computed Tomography, Indocyanine Green Solution

Active — Not RecruitingPhase 2

NCT02834013

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipil…

United States818 participantsStarted 2017-01-30

Treatment: Biospecimen Collection, Computed Tomography

Mixed Mesodermal (Mullerian) Tumor

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci…

All recent trials (7 shown)

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci…

All recent trials (7 shown)

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansi…

Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Pe…

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ova…

Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus